Multiple Sclerosis (MS) Treatment

GAPS IN TREATING PROGRESSIVE MS DESPITE HIGH INFLAMMATORY CONTROL
Modern MS therapies are highly effective at controlling acute inflammation, with success rates exceeding 90%. However, few options exist to address the progressive loss of function that defines advanced MS.



MINERVE’S FOCUS ON NEUROPROTECTION AND FUNCTIONAL PRESERVATION IN MS
Minerve’s innovative approach targets the underlying mechanisms of disease progression, aiming to preserve and restore neurological function. This is one of the greatest unmet needs in developing therapeutics to stop the accumulation of disability for people living with MS.